Greycroft

Founded in 2006, Greycroft is a venture capital firm based in New York and Los Angeles. With over $1 billion under management, it focuses on early-stage investments in consumer internet, financial technology, healthcare, and enterprise software sectors across the United States. The firm leverages its extensive network of media and technology industry connections to help entrepreneurs gain visibility, build strategic relationships, and bring products to market.

William Agathis

Investor

Kamran Ansari

Venture Partner

Adam Boutin

Partner

Nick Crance

Principal

Conor Deveney

Principal

Past deals in Oregon

Boulder Care

Series B in 2022
Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

Brave Care

Series B in 2021
Brave Care operates pediatric primary and urgent care clinics in Oregon and Texas, offering both emergency and non‑emergency services. The clinics provide treatment for common childhood conditions such as allergies, asthma, ear pain, fever, minor fractures, and urinary tract infections, as well as on‑site laboratory and X‑ray services. A team of pediatric doctors and medical professionals delivers care in a child‑friendly environment designed to reduce the stress and cost associated with emergency medicine. The company also offers a website and mobile app that give parents nationwide access to pediatric advice and support. Founded in 2019 and headquartered in Portland, Oregon, Brave Care focuses on improving access to quality pediatric care.

Brave Care

Series A in 2021
Brave Care operates pediatric primary and urgent care clinics in Oregon and Texas, offering both emergency and non‑emergency services. The clinics provide treatment for common childhood conditions such as allergies, asthma, ear pain, fever, minor fractures, and urinary tract infections, as well as on‑site laboratory and X‑ray services. A team of pediatric doctors and medical professionals delivers care in a child‑friendly environment designed to reduce the stress and cost associated with emergency medicine. The company also offers a website and mobile app that give parents nationwide access to pediatric advice and support. Founded in 2019 and headquartered in Portland, Oregon, Brave Care focuses on improving access to quality pediatric care.

Boulder Care

Series A in 2020
Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

Brave Care

Seed Round in 2019
Brave Care operates pediatric primary and urgent care clinics in Oregon and Texas, offering both emergency and non‑emergency services. The clinics provide treatment for common childhood conditions such as allergies, asthma, ear pain, fever, minor fractures, and urinary tract infections, as well as on‑site laboratory and X‑ray services. A team of pediatric doctors and medical professionals delivers care in a child‑friendly environment designed to reduce the stress and cost associated with emergency medicine. The company also offers a website and mobile app that give parents nationwide access to pediatric advice and support. Founded in 2019 and headquartered in Portland, Oregon, Brave Care focuses on improving access to quality pediatric care.

Amplion

Series A in 2019
Amplion Inc. is a biotechnology company based in Bend, Oregon, that operates BiomarkerBase, a comprehensive database focused on clinical biomarkers. This platform offers detailed information about molecular biomarkers tested in clinical settings, enabling strategic decision-making regarding their commercial use. Amplion's biomarker engine serves as an end-to-end workflow tool, facilitating the extraction, filtering, annotation, and analysis of both structured and unstructured data. Additionally, the company provides an alert service that notifies users via email whenever specific biomarkers or diseases are involved in new tests, drug labels, or clinical trials. Founded in 2013, Amplion leverages machine learning to enhance the biomedical landscape and identify opportunities within drug research and development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.